Literature DB >> 26776886

Transcriptional Control of Somatic Cell Reprogramming.

Yan Xu1, Meng Zhang2, Wenjuan Li2, Xihua Zhu1, Xichen Bao1, Baoming Qin3, Andrew P Hutchins4, Miguel A Esteban5.   

Abstract

Somatic cells and pluripotent cells display remarkable differences in most aspects of cell function. Accordingly, somatic cell reprogramming by exogenous factors requires comprehensive changes in gene transcription to induce a forced pluripotent state, which is encompassed by a simultaneous transformation of the epigenome. Nevertheless, how the reprogramming factors and other endogenous regulators coordinate to suppress the somatic cell gene program and activate the pluripotency gene network, and why the conversion is multi-phased and lengthy, remain enigmatic. We summarize the current knowledge of transcriptional regulation in somatic cell reprogramming, and highlight new perspectives that may help to reshape existing paradigms.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Keywords:  epigenetic remodeling; genome architecture; pioneer transcription factors; somatic cell reprogramming; transcriptional regulation

Mesh:

Substances:

Year:  2016        PMID: 26776886     DOI: 10.1016/j.tcb.2015.12.003

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  12 in total

Review 1.  Signaling pathways regulating cartilage growth plate formation and activity.

Authors:  William E Samsa; Xin Zhou; Guang Zhou
Journal:  Semin Cell Dev Biol       Date:  2016-07-11       Impact factor: 7.727

2.  Impaired differentiation potential of CD34-positive cells derived from mouse hair follicles after long-term culture.

Authors:  Yukiteru Ouji; Masayasu Misu; Tomotaka Kitamura; Daisuke Okuzaki; Masahide Yoshikawa
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

Review 3.  Combination of the modulators of epigenetic machinery and specific cell signaling pathways as a promising approach for cell reprogramming.

Authors:  Arshak R Alexanian
Journal:  Mol Cell Biochem       Date:  2022-05-03       Impact factor: 3.842

4.  Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming.

Authors:  Ayyub Ebrahimi; Kenan Sevinç; Gülben Gürhan Sevinç; Adam P Cribbs; Martin Philpott; Fırat Uyulur; Tunç Morova; James E Dunford; Sencer Göklemez; Şule Arı; Udo Oppermann; Tamer T Önder
Journal:  Nat Chem Biol       Date:  2019-04-08       Impact factor: 15.040

Review 5.  The essentiality of non-coding RNAs in cell reprogramming.

Authors:  Joachim Luginbühl; Divya Mundackal Sivaraman; Jay W Shin
Journal:  Noncoding RNA Res       Date:  2017-04-13

6.  WDR5, BRCA1, and BARD1 Co-regulate the DNA Damage Response and Modulate the Mesenchymal-to-Epithelial Transition during Early Reprogramming.

Authors:  Georgina Peñalosa-Ruiz; Vicky Bousgouni; Jan P Gerlach; Susan Waarlo; Joris V van de Ven; Tim E Veenstra; José C R Silva; Simon J van Heeringen; Chris Bakal; Klaas W Mulder; Gert Jan C Veenstra
Journal:  Stem Cell Reports       Date:  2019-03-14       Impact factor: 7.765

7.  NANOG and LIN28 dramatically improve human cell reprogramming by modulating LIN41 and canonical WNT activities.

Authors:  Ling Wang; Yue Su; Chang Huang; Yexuan Yin; Alexander Chu; Alec Knupp; Young Tang
Journal:  Biol Open       Date:  2019-12-05       Impact factor: 2.422

8.  Glis family proteins are differentially implicated in the cellular reprogramming of human somatic cells.

Authors:  Seo-Young Lee; Hye Bin Noh; Hyeong-Taek Kim; Kang-In Lee; Dong-Youn Hwang
Journal:  Oncotarget       Date:  2017-08-18

9.  Generation of a biotinylatable Sox2 mouse model to identify Sox2 complexes in vivo.

Authors:  Kim Schilders; Evelien Eenjes; Gabriëla Edel; Anne Boerema de Munck; Marjon Buscop van Kempen; Jeroen Demmers; René Wijnen; Dick Tibboel; Robbert J Rottier
Journal:  Transgenic Res       Date:  2018-01-30       Impact factor: 2.788

10.  NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.

Authors:  Thach Mai; Glenn J Markov; Jennifer J Brady; Adelaida Palla; Hong Zeng; Vittorio Sebastiano; Helen M Blau
Journal:  Nat Cell Biol       Date:  2018-07-16       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.